Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05339308 |
Other study ID # |
MG-MCP2022 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 1, 2022 |
Est. completion date |
September 1, 2022 |
Study information
Verified date |
October 2022 |
Source |
University of Ljubljana |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study will aim to investigate the effects of magnesium oil administration on skeletal
muscle contractile properties.
Description:
Aim: This study will aim to investigate the effects of magnesium oil administration on
skeletal muscle contractile properties (SMcp).
Design: Randomized controlled study
Participants: For this purpose, investigators will recruit 40 recreationally active and
healthy adults of both sexes (18-35 years of age).
Methods: The experimental leg (EXP) will receive the 10 sprays of magnesium oil (20 mg per
spray) that will be topically applied to the skin covering the knee extensor muscles, whereas
the control leg (CON) will receive 10 sprays of natural mineral-free oil. The vastus
lateralis SMcp will be measured by using a tensiomyography (TMG) device before application
(PRE) and after 10 (POST10), 20 (POST20), 30 (POST30), 40 (POST40), and 50 (POST50) minutes
of application onset, respectively.